NL-OMON24959
Recruiting
Not Applicable
Reduce Bladder Cancer Recurrence In Patients Treated For Upper Urinary Tract Urothelial Carcinoma
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Erasmus university Medical Center
- Enrollment
- 170
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Histologically proven urothelial carcinoma of the upper urinary tract with or without concurrent carcinoma in situ (CIS only is allowed) or patients with a suspicion of a urothelial carcinoma of the UUT on CT\-scan plus a urinary cytology sample showing high\-grade urothelial carcinoma;
- •\-Patients planned to be treated either by partial ureterectomy or by a radical nephro\-ureterectomy (open or laparoscopic) including a bladder cuff;
Exclusion Criteria
- •\- If pre\-operative histology by biopsy shows aberrant histology of the UUT tumor of \>50% (adenocarcinoma, small cell carcinoma, squamous cell carcinoma).
- •\- History or presence of a malignant tumor or carcinoma in situ of the bladder.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
REduce BlAdder CAncer REcurrence in patients treated for upper urinary tract urothelial carcinoma (REBACARE Trial)pper Tract Urothelial Carcinoma (UTUC).MedDRA version: 20.0Level: HLGTClassification code 10038364Term: Renal and urinary tract neoplasms malignant and unspecifiedSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: HLGTClassification code 10038365Term: Renal and urinary tract therapeutic proceduresSystem Organ Class: 10042613 - Surgical and medical proceduresTherapeutic area: Diseases [C] - Cancer [C04]EUCTR2017-000949-53-NLErasmus MC, Dept. Urology190
Completed
Phase 4
REduce BlAdder CAncer REcurrence in patients treated for upper urinary tract urothelial carcinoma (REBACARE Trial)urothelial cancer of the upper urinary tractUrothelial carcinoma of the upper urinary tract1003836410046400NL-OMON50424Erasmus MC, Universitair Medisch Centrum Rotterdam190
Active, not recruiting
Phase 1
Treatment Of Metastatic Bladder cancer at the time Of biochemical reLApse following radical cystectomy - TOMBOLArothelial cancerTherapeutic area: Diseases [C] - Male Urogenital Diseases [C12]Therapeutic area: Diseases [C] - Female Urogenital Diseases and Pregnancy Complications [C13]CTIS2024-510865-41-00Aarhus Universitetshospital282
Recruiting
Not Applicable
Prevention of TaT1 bladder cancer by BCG instillation: Induction alone versus induction and maintenanceJPRN-UMIN000009508Department of Urology and Andrology, Kansai Medical university160
Active, not recruiting
Not Applicable
TREATMENT OF NON-INVASIVE BLADDER CANCER WITH HIGH RISK OF RECURRENCE – BLUE LIGHT CYSTOSCOPY WITH CHEMOTHERAPYbladder cancer (non-invasive Ta urothelial bladder cancer)Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2012-000559-15-FIFinnBladder